*** RSVP on Eventbrite: https://www.eventbrite.com/e/the-future-is-female-female-health-and-reproductive-technologies-tickets-120680447467 ***
Half the world's population is female, but female-specific health problems are often overlooked. Listen to three founders changing that, by bringing new technologies to market and by de-stigmatizing the conversations around these issues. Learn about their innovative solutions to reproductive and intimate health problems.
This event includes startup pitches, panel discussion, Q&A, and breakout rooms to meet the companies.
Speakers:
Chiara Heide, CEO of Brightcure
COMBATING UTIs WITH PROBIOTIC PREDATOR BACTERIA
50% of women and 12% of men suffer from urinary tract infections (UTIs) during their lifetime. Current UTI treatments present problems that include low efficacy, unwanted side effects, and accelerated development of antibiotic-resistant infections. Brightcure is solving the problem of poor treatment options for patients with recurrent UTIs by harnessing healthy, natural bacterial solutions to reduce the overuse of antibiotics.
Gabriela Gutiérrez, CEO of Microgenesis
FUTURE OF FERTILITY
In a research study, Microgenesis began working with 40 fertility clinics, treating 287 women who had failed all attempts to get pregnant, including at least four expensive IVF treatments. These patients were beyond hope. With Microgenesis’ method of diagnosis and natural treatment, 75% of the women got pregnant. Microgenesis uses microRNA signatures, on swabs from both the gut and fertility biome, to diagnose dysbiosis and treat patients with neutraceuticals and diet-change. They intend to expand through fertility clinics, as well as cultivate a direct-to-consumer brand for women just beginning the journey.
Colin Bortner, CEO of Ivy Natal
THE FUTURE OF FERTILITY
Ivy Natal is developing a novel process to create healthy human egg cells from skin cells, giving women the confidence in their ability to choose whether and when to have a child. Many fertility patients cannot have children except through the use of donor eggs. This can be due to surgery, chemotherapy, maternal age, or genetic conditions. Ivy Natal aims to enable these parents to have genetic children for the first time.
